Holen Sie sich die Stockscreener-App
26.97
0.52%
0.14
Handel nachbörslich:
26.97
Schlusskurs vom Vortag:
$26.83
Offen:
$26.65
24-Stunden-Volumen:
89,549
Relative Volume:
0.29
Marktkapitalisierung:
$176.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-74.14M
KGV:
-2.3679
EPS:
-11.39
Netto-Cashflow:
$-65.70M
1W Leistung:
+2.51%
1M Leistung:
+10.13%
6M Leistung:
+13.08%
1J Leistung:
+160.58%
1-Tages-Spanne:
$25.79
$27.55
1-Wochen-Bereich:
$25.00
$29.67
52-Wochen-Spanne:
$9.90
$92.00
Instil Bio Inc Stock (TIL) Company Profile
Firmenname
Instil Bio Inc
Sektor
Branche
Telefon
(972) 499-3350
Adresse
3963 MAPLE AVENUE, DALLAS
Vergleichen Sie TIL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
26.97 | 176.00M | 0 | -74.14M | -65.70M | -11.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Instil Bio Inc Stock (TIL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-11-04 | Eingeleitet | JMP Securities | Mkt Perform |
| 2024-04-12 | Herabstufung | Jefferies | Buy → Hold |
| 2022-11-01 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-11-01 | Herabstufung | Truist | Buy → Hold |
| 2021-08-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-04-13 | Eingeleitet | Cowen | Outperform |
| 2021-04-13 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-04-13 | Eingeleitet | Truist | Buy |
Alle ansehen
Instil Bio Inc Aktie (TIL) Neueste Nachrichten
Instil Bio Posts Wider Loss in Q2, Cash Reserves Decline to $103.6 Million - AInvest
Instil Bio, Inc. SEC 10-Q Report - TradingView
Instil Bio Posts Wider Loss in Q2 - The Motley Fool
Instil Bio Posts Wider Loss in Q2 - Nasdaq
Applying chart zones and confluence areas to Instil Bio Inc.July 2025 News Drivers & Daily Technical Forecast Reports - Newser
Instil Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Instil Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Instil Bio reports Q2 financials, '2510 IND cleared by US FDA. - AInvest
Instil Bio Inc. Testing Reversal Zone on Weekly Chart2025 Performance Recap & Safe Capital Allocation Plans - beatles.ru
Instil Bio Advances Lung Cancer Treatment Pipeline as FDA Clears Key Drug Trial - Stock Titan
Best data tools to analyze Instil Bio Inc. stockJuly 2025 Macro Moves & Real-Time Volume Triggers - Newser
Published on: 2025-08-12 21:39:14 - Newser
Instil Bio Inc.’s volatility index tracking explainedFree Real Market Momentum Signal Generator - Newser
What MACD and RSI say about Instil Bio Inc.Buy Alert Based on RSI and Volume - Newser
Will Instil Bio Inc. stock benefit from interest rate changesFree Real Trader Watchlist of Hot Stocks - Newser
How to manage a losing position in Instil Bio Inc.Free AI-Powered Trade Planning with Indicators - Newser
Chart based analysis of Instil Bio Inc. trendsWeekly Market Direction and Sector Summary - Newser
Sectors Driving Future Growth for Instil Bio Inc. StockFree Weekly Setup With 3x Return Potential - Newser
When is the best time to buy Instil Bio Inc. stockSmart Chart Forecasting with AI Algorithms - Newser
Using RSI to spot recovery in Instil Bio Inc.Market Forecast Summary Over Multi-Year Period - Newser
Instil Bio TIL Q2 2025 Earnings Preview Upside Potential Driven by New Product Launch - AInvest
Why Instil Bio Inc. is moving todayAI Powered Stock Market Trend Forecast - Newser
Is Instil Bio Inc. reversing from oversold territoryValue Investing Summary and Earnings Outlook - Newser
How sentiment analysis helps forecast Instil Bio Inc.Insider Strategy for High Conviction Picks - Newser
Does Instil Bio Inc. stock perform well during market downturnsUnlock exclusive trading strategies for gains - Jammu Links News
Is Instil Bio Inc. stock overvalued or undervaluedUnlock daily market insights for better trades - Jammu Links News
How does Instil Bio Inc. compare to its industry peersInvest like a pro with expert recommendations - Jammu Links News
What is Instil Bio Inc. company’s growth strategyPowerful growth strategies - Jammu Links News
Is Instil Bio Inc. a growth stock or a value stockInvest confidently with data-driven strategies - Jammu Links News
How strong is Instil Bio Inc. company’s balance sheetBuild wealth steadily with proven methods - Jammu Links News
How does Instil Bio Inc. generate profit in a changing economyExceptional gains - Jammu Links News
What are analysts’ price targets for Instil Bio Inc. in the next 12 monthsGet professional advice for portfolio optimization - Jammu Links News
What analysts say about Instil Bio Inc. stockInvest confidently with proven investment plans - Jammu Links News
How many analysts rate Instil Bio Inc. as a “Buy”Unlock exclusive trading strategies for gains - Jammu Links News
What is the risk reward ratio of investing in Instil Bio Inc. stockGet expert alerts on market-moving stocks - Jammu Links News
What are the latest earnings results for Instil Bio Inc.Superior capital gains - Jammu Links News
Should I hold or sell Instil Bio Inc. stock in 2025Unlock powerful portfolio optimization tools - Jammu Links News
What makes Instil Bio Inc. stock price move sharplyInvest in stocks with strong fundamentals - Jammu Links News
How volatile is Instil Bio Inc. stock compared to the marketDiscover dynamic stocks ready to soar - Jammu Links News
Instil Bio Inc. Stock Analysis and ForecastBuild a winning portfolio with smart picks - Jammu Links News
Finanzdaten der Instil Bio Inc-Aktie (TIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):